Vimarsana
Biggest News Aggregation in the World

Page 24 - Aser Surgery News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aser Surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aser Surgery Today - Breaking & Trending Today

Limiting Cyberattack Blast Radius for Healthcare SaaS - Vimarsana News

Limiting Cyberattack Blast Radius for Healthcare SaaS

From our experience providing identity management services to healthcare SaaS companies, here are five rules for building more secure SaaS applications. The list can serve as a guide either for healthcare organizations looking to move key operations to SaaS or to makers of SaaS applications for healthcare customers.

Contrasting Provider-To-Consumer vs Direct-To-Consumer Healthcare Model - Vimarsana News

Contrasting Provider-To-Consumer vs Direct-To-Consumer Healthcare Model

With the PTC model, providers can remain independent, continue "driving the bus," generate revenue for their practice, treat more patients virtually and scale their practice like never before.

Everly Health Partners With National Kidney Foundation, Expands Kidney Health Testing Suite - Vimarsana News

Everly Health Partners With National Kidney Foundation, Expands Kidney Health Testing Suite

Everly Health has formed a partnership with the National Kidney Foundation to improve education about chronic kidney disease. It has also expanded its diabetes monitoring and kidney health testing suite for health plans and employers.

Brain Patterns, Physiological Metrics Show VR's Ability To Reduce Chronic Pain In New Research - Vimarsana News

Brain Patterns, Physiological Metrics Show VR's Ability To Reduce Chronic Pain In New Research

AppliedVR released study results demonstrating VR’s ability to help patients suffering from chronic low back pain. The technology was able to increase participants' brain coherence and help them achieve a slower breathing rate — two metrics associated with reduced pain.

Moderna & Ionis-Partnered Biotech Lands $94M in IPO Cash for Gene-Editing R&D - Vimarsana News

Moderna & Ionis-Partnered Biotech Lands $94M in IPO Cash for Gene-Editing R&D

Metagenomi finds novel gene-editing tools by mining microbial samples from around the world. Already partnered with Moderna and Ionis Pharmaceuticals, the company said its IPO cash will support ongoing preclinical research.